VitaNova Life Sciences Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

VitaNova Life Sciences Corp reported Cash And Cash Equivalents At Carrying Value of $8.7 thousand for the year ending 2023.

  • VitaNova Life Sciences Corp showed a decrease of -62.2% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from VitaNova Life Sciences Corp's annual report (Form 10-K), filed with the SEC on May 15, 2023.
  • XBRL data for this metric is available from 2017 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2017 to 2023), VitaNova Life Sciences Corp's Cash And Cash Equivalents At Carrying Value has grown by 4,157.6%.
  • Historical annual values: Fiscal year 2023: $8.7 thousand | Fiscal year 2022: $23.1 thousand | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $4.4 thousand | Fiscal year 2017: $205.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: